| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | Reumuth Mary | CHIEF FINANCIAL OFFICER | Jan 04, 2024 | Sale | $6.74 | 1,227 | 8,270 | 66,136 | Jan 05, 2024, 04:04 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Reumuth Mary | CHIEF FINANCIAL OFFICER | Jan 04, 2023 | Sale | $28.54 | 60 | 1,712 | 11,883 | Jan 06, 2023, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Reumuth Mary | CHIEF FINANCIAL OFFICER | Oct 26, 2022 | Sale | $6.51 | 194 | 1,263 | 2,418 | Oct 28, 2022, 04:15 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Reumuth Mary | CHIEF FINANCIAL OFFICER | Jun 27, 2022 | Sale | $0.37 | 2,613 | 967 | 130,595 | Jun 29, 2022, 08:12 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Reumuth Mary | CHIEF FINANCIAL OFFICER | Jan 04, 2022 | Sale | $1.30 | 2,850 | 3,705 | 133,208 | Jan 05, 2022, 08:00 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Reumuth Mary | CHIEF FINANCIAL OFFICER | Oct 26, 2021 | Sale | $1.80 | 9,449 | 17,008 | 136,058 | Oct 28, 2021, 08:04 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Reumuth Mary | CHIEF FINANCIAL OFFICER | Jun 28, 2021 | Sale | $5.77 | 2,452 | 14,148 | 145,507 | Jun 29, 2021, 05:26 PM | |
| KALA | Kala Pharmaceuticals, Inc. | Reumuth Mary | Chief Financial Officer | Jun 09, 2020 | Option Exercise | $2.64 | 43,477 | 114,771 | 48,293 | Jun 11, 2020, 04:58 PM |
Menu